- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Addressing the Demand for Mental Health Services During the COVID-19 Pandemic
On this episode of Managed Care Cast, we speak with Gregory Harris, MD, MPH, DFAPA, senior medical director for behavioral health at Blue Cross Blue Shield of Massachusetts, about the challenges of meeting the demand for mental health service during the COVID-19 pandemic.
The COVID-19 pandemic has led to an unprecedented boom in telehealth use, especially when it comes to services provided for mental health. With the combined toll of a global pandemic, economic hardships, and protracted grief, Americans’ mental health has jumped to the forefront of the national conversation.
A recent analysis, published by Blue Cross Blue Shield of Massachusetts, illustrates this seismic shift in care delivery and demand for mental health services. Researchers compiled claims data from March through December of 2019 and compared it with the same time frame in 2020.
To learn more about the report’s findings and to understand the challenges of providing these services to patients during a pandemic, we spoke with Gregory Harris, MD, MPH, DFAPA, the senior medical director for behavioral health at Blue Cross Blue Shield of Massachusetts.
On this episode of Managed Care Cast, Harris describes his experience as a psychiatrist and offers some solutions to meet the growing demand for this field in the months and years following COVID-19.
Listen above or through one of these podcast services:
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More
